Dose‐adjusted asparaginase (including lowering and/or capping doses) in adults is generally tolerable in patients with ALL across age spectrums. In addition, pediatric inspired regimens may offer other benefits, such as fewer late occurring health complications, such as retaining fertility, which reflects on the long‐term cost to the health care system. The gene discussed is ASPG; the disease is acute lymphoblastic leukemia.